Inmagene Biopharmaceuticals Funding & Investors
It is a leading biotech company focused on immunology-related therapeutic areas.
inmagenebio.comTotal Amount Raised: $121,000,000
Inmagene Biopharmaceuticals Funding Rounds
Series C
$100,000,000
Series C Investors
HighLight CapitalPanacea VentureSouth China Venture CapitalVMS Asset ManagementTriWise CapitalKunlun FundHT CapitalTMT InvestmentsSeries B
$21,000,000
Series B Investors
Vertex Ventures ChinaPanacea VentureSouth China Venture CapitalKunlun Capital
Funding info provided by Diffbot.